(Full-year report 2022)
(Current pipeline on website as of 2023)
The program is split into two separate streams, the ligament indication is still pending large animal study as they suggested in their report initially.
The other stream is progressing into further human trials after the previous results.
You're mixing up the streams, they haven't released any animal study data because there is none.
- Forums
- ASX - By Stock
- Ann: Investor Presentation
(Full-year report 2022)(Current pipeline on website as of...
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
0.005(1.39%) |
Mkt cap ! $76.40M |
Open | High | Low | Value | Volume |
36.5¢ | 37.0¢ | 36.0¢ | $2.864K | 7.871K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 136618 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 4400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 86618 | 0.360 |
6 | 27365 | 0.355 |
7 | 149716 | 0.350 |
4 | 108988 | 0.345 |
1 | 25000 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 4400 | 1 |
0.370 | 11312 | 2 |
0.375 | 32756 | 2 |
0.380 | 6345 | 2 |
0.385 | 72893 | 2 |
Last trade - 15.53pm 26/06/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |